• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病患者家庭成员的筛查可发现其中未被诊断的非酒精性脂肪性肝病:是否存在遗传联系?

Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?

作者信息

Jain Shubham, Thanage Ravi, Panchal Falguni, Rathi Pravin M, Munshi Renuka, Udgirkar Suhas S, Contractor Qais Q, Chandnani Sanjay J, Sujit Nair P, Debnath Partha, Singh Anupam

机构信息

Department of Gastroenterology, Topiwala National Medical College and BYL Ch Hospital, Dr. A.L Nair Road, Mumbai, Maharashtra, 400 008, India.

Molecular Genetic Laboratory, Department of Clinical Pharmacology, Topiwala National Medical College and BYL Nair Ch.Hospital, Dr.AL Nair Road, Mumbai, Maharashtra, 400 008, India.

出版信息

J Clin Exp Hepatol. 2021 Jul-Aug;11(4):466-474. doi: 10.1016/j.jceh.2020.10.003. Epub 2020 Oct 10.

DOI:10.1016/j.jceh.2020.10.003
PMID:34276153
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8267349/
Abstract

BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) has multifactorial origin. Genetic and environmental factors lead to the biology of this complex disorder. In this study, we screened parents of cases with NAFLD and compared them with parents of cases without NAFLD to see its familial aggregation and the role of patatin-like phospholipase domain containing 3 (PNPLA3).

METHOD

It was a cross-sectional study. Parents of probands with NAFLD and without NAFLD were screened with abdominal sonography, anthropometry, blood tests, transient elastography, and PNPLA3 polymorphism.

RESULTS

We had enrolled 303 individuals: 51 probands with NAFLD, 50 probands without NAFLD, and their 202 parents. Parents of the NAFLD group had significantly higher metabolic risk factors as compared with parents of the non-NAFLD group. They had a significantly higher rate of fatty liver ( = 0.0001), mean serum aspartate aminotransferase levels ( = 0.011), mean serum alanine aminotransferase levels ( = 0.001),raised fasting and postprandial blood sugar levels, lower mean platelets (P = 0.033) and serum albumin levels ( = 0.005), and higher mean liver stiffness ( = 0.001) on transient elastography.Frequency of PNPLA3 polymorphism within NAFLD group was higher compared to the non-NAFLD group (mutant GG-13.3 vs 3.3%). Similarly, parents of NAFLD group had mutant GG in 15 % versus 5% in parents of non-NAFLD group, ( = 0.105, odds ratio 6), though it was not statistically significant but may be relevant. In this study, offsprings of parents with nonalcoholic steatohepatitis were likely to have GG homozygous allele. A NAFLD16 score based on parent's parameters was calculated to predict the probability of NAFLD occurrence in an overweight obese individual.

CONCLUSION

Screening of parents of individuals with NAFLD will help in the identification of undiagnosed NAFLD cases and other metabolic risk factors among them as there is a familial aggregation of NAFLD. One can predict the occurrence of NAFLD in the next generation using the NAFLD16 score.

摘要

背景与目的

非酒精性脂肪性肝病(NAFLD)病因多因素。遗传和环境因素导致了这种复杂疾病的生物学特性。在本研究中,我们对NAFLD病例的父母进行筛查,并与无NAFLD病例的父母进行比较,以观察其家族聚集性以及含patatin样磷脂酶结构域3(PNPLA3)的作用。

方法

这是一项横断面研究。对患有NAFLD和未患有NAFLD的先证者的父母进行腹部超声、人体测量、血液检查、瞬时弹性成像和PNPLA3基因多态性筛查。

结果

我们纳入了303名个体:51名患有NAFLD的先证者、50名未患有NAFLD的先证者以及他们的202名父母。与非NAFLD组的父母相比,NAFLD组的父母有显著更高的代谢危险因素。他们有显著更高的脂肪肝发生率(P = 0.0001)、平均血清天冬氨酸氨基转移酶水平(P = 0.011)、平均血清丙氨酸氨基转移酶水平(P = 0.001)、空腹和餐后血糖水平升高、平均血小板较低(P = 0.033)和血清白蛋白水平较低(P = 0.005),以及在瞬时弹性成像上有更高的平均肝脏硬度(P = 0.001)。NAFLD组中PNPLA3基因多态性的频率高于非NAFLD组(突变型GG - 13.3%对3.3%)。同样,NAFLD组的父母中有15%携带突变型GG,而非NAFLD组的父母中为5%,(P = 0.105,优势比6),虽然无统计学意义但可能相关。在本研究中,患有非酒精性脂肪性肝炎的父母的后代更可能有GG纯合等位基因。基于父母参数计算出NAFLD16评分,以预测超重肥胖个体发生NAFLD的概率。

结论

对NAFLD个体的父母进行筛查将有助于识别未诊断的NAFLD病例及其它代谢危险因素,因为存在NAFLD的家族聚集性。使用NAFLD16评分可以预测下一代NAFLD的发生。

相似文献

1
Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?非酒精性脂肪性肝病患者家庭成员的筛查可发现其中未被诊断的非酒精性脂肪性肝病:是否存在遗传联系?
J Clin Exp Hepatol. 2021 Jul-Aug;11(4):466-474. doi: 10.1016/j.jceh.2020.10.003. Epub 2020 Oct 10.
2
Association of PNPLA3 I148M with Liver Disease Biomarkers in Latinos.载脂蛋白 L3 I148M 多态性与拉丁裔人群肝脏疾病生物标志物的关联。
Hum Hered. 2021;86(1-4):21-27. doi: 10.1159/000520734. Epub 2021 Nov 8.
3
Prevalence and Predictors of Nonalcoholic Fatty Liver Disease in Family Members of Patients With Nonalcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者家庭成员中非酒精性脂肪性肝病的患病率及预测因素
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):362-371. doi: 10.1016/j.jceh.2021.07.013. Epub 2021 Jul 31.
4
The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population.载脂蛋白基因 PNPLA3 I148M 多态性与血糖正常人群的胰岛素抵抗和非酒精性脂肪性肝病相关。
Liver Int. 2011 Oct;31(9):1326-31. doi: 10.1111/j.1478-3231.2011.02526.x. Epub 2011 Apr 5.
5
Vitamin E reduces liver stiffness in nonalcoholic fatty liver disease.维生素E可降低非酒精性脂肪性肝病患者的肝脏硬度。
World J Hepatol. 2015 Nov 28;7(27):2749-56. doi: 10.4254/wjh.v7.i27.2749.
6
Indian National Association for Study of the Liver (INASL) Guidance Paper on Nomenclature, Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD).印度国家肝脏研究协会(INASL)关于非酒精性脂肪性肝病(NAFLD)命名、诊断和治疗的指导文件。
J Clin Exp Hepatol. 2023 Mar-Apr;13(2):273-302. doi: 10.1016/j.jceh.2022.11.014. Epub 2022 Dec 7.
7
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.瘦型非酒精性脂肪性肝病患者的肝脏和心血管损伤,及其与内脏肥胖的关系。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26.
8
Liver Stiffness Measurement by Using Transient Elastography in Bangladeshi Patients with Type 2 Diabetes Mellitus and Ultrasonography-Diagnosed Nonalcoholic Fatty Liver Disease.在孟加拉国2型糖尿病患者及超声诊断的非酒精性脂肪性肝病患者中使用瞬时弹性成像技术测量肝脏硬度
Diabetes Metab Syndr Obes. 2021 Jul 6;14:3089-3096. doi: 10.2147/DMSO.S317876. eCollection 2021.
9
Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.非酒精性脂肪性肝病无创性纤维化工具:APRI、BARD、FIB-4、NAFLD 纤维化评分和 Hepamet 纤维化评分在葡萄牙人群中的验证。
Postgrad Med. 2022 May;134(4):435-440. doi: 10.1080/00325481.2022.2058285. Epub 2022 Mar 30.
10
Genetic variation in the patatin-like phospholipase domain-containing protein-3 (PNPLA-3) gene in Asian Indians with nonalcoholic fatty liver disease.亚洲印第安人非酒精性脂肪性肝病中 patatin 样磷脂酶结构域蛋白 3(PNPLA-3)基因的遗传变异。
Metab Syndr Relat Disord. 2013 Oct;11(5):329-35. doi: 10.1089/met.2012.0064. Epub 2013 Jun 4.

引用本文的文献

1
Preventive hepatology at AIIMS Rishikesh: Delivering comprehensive and integrated care for liver diseases in Northern state of India.全印医学科学研究所瑞诗凯诗分院的预防肝脏病学:为印度北部邦的肝脏疾病提供全面综合的护理。
J Family Med Prim Care. 2024 Jan;13(1):28-35. doi: 10.4103/jfmpc.jfmpc_1536_23. Epub 2024 Feb 8.
2
Non-alcoholic fatty liver disease and the impact of genetic, epigenetic and environmental factors in the offspring.非酒精性脂肪性肝病及其遗传、表观遗传和环境因素对子代的影响。
World J Gastroenterol. 2022 Jul 7;28(25):2890-2899. doi: 10.3748/wjg.v28.i25.2890.

本文引用的文献

1
Transient hepatic elastography has the best performance to evaluate liver fibrosis in non-alcoholic fatty liver disease (NAFLD).瞬时弹性成像在评估非酒精性脂肪性肝病 (NAFLD) 患者的肝纤维化方面具有最佳性能。
Ann Hepatol. 2019 May-Jun;18(3):445-449. doi: 10.1016/j.aohep.2018.09.003. Epub 2019 Apr 12.
2
Genetics of nonalcoholic fatty liver disease in Asian populations.亚洲人群非酒精性脂肪性肝病的遗传学
J Genet. 2019 Mar;98.
3
Genetics of Nonalcoholic Fatty Liver Disease: From Pathogenesis to Therapeutics.非酒精性脂肪性肝病的遗传学:从发病机制到治疗。
Semin Liver Dis. 2019 May;39(2):124-140. doi: 10.1055/s-0039-1679920. Epub 2019 Mar 25.
4
Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: A meta-analysis.PNPLA3基因rs738409多态性与非酒精性脂肪性肝病(NAFLD)易感性及严重程度的关联:一项荟萃分析。
Medicine (Baltimore). 2019 Feb;98(7):e14324. doi: 10.1097/MD.0000000000014324.
5
Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables.促进非酒精性脂肪性肝病的遗传学研究:通过多态性和临床变量联合风险评分。
World J Gastroenterol. 2018 Nov 21;24(43):4835-4845. doi: 10.3748/wjg.v24.i43.4835.
6
Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis.非酒精性脂肪性肝病肝硬化患者照护者中非酒精性脂肪性肝病的流行率和严重程度。
Clin Gastroenterol Hepatol. 2019 Sep;17(10):2132-2133. doi: 10.1016/j.cgh.2018.11.008. Epub 2018 Nov 15.
7
Study of Family Clustering and PNPLA3 Gene Polymorphism in Pediatric Non Alcoholic Fatty Liver Disease.儿童非酒精性脂肪性肝病的家族聚集性及PNPLA3基因多态性研究
Indian Pediatr. 2018 Jul 15;55(7):561-567.
8
Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.振动控制瞬时弹性成像评估非酒精性脂肪性肝病患者的纤维化和脂肪变性。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):156-163.e2. doi: 10.1016/j.cgh.2018.04.043. Epub 2018 Apr 26.
9
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病和非酒精性脂肪性肝炎的全球负担:趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2018 Jan;15(1):11-20. doi: 10.1038/nrgastro.2017.109. Epub 2017 Sep 20.
10
New trends on obesity and NAFLD in Asia.亚洲肥胖和非酒精性脂肪性肝病的新趋势。
J Hepatol. 2017 Oct;67(4):862-873. doi: 10.1016/j.jhep.2017.06.003. Epub 2017 Jun 19.